Grants and Contributions:

Title:
The Covid-19 Accessibility Resources for Employers (CARE) Program
Agreement Number:
17349242
Agreement Value:
$850,000.00
Agreement Date:
Aug 31, 2020 - Mar 31, 2021
Description:
This project is in line with the program stream objectives as it supports projects that will help employers set up accessible and effective measures, including supports and accommodations, to make workplaces more inclusive in response to COVID-19. This includes: • Setting up accessible and effective work-from-home measures • Expanding online training opportunities • Creating inclusive workplaces, whether virtual or physical • Connecting people with disabilities and employers • Training for in-demand jobs • Wage subsidies
Organization:
Employment and Social Development Canada
Expected Results:

This project is in line with the program stream objectives as it supports projects that will help employers set up accessible and effective measures, including supports and accommodations, to make workplaces more inclusive in response to COVID-19. This includes:
• Setting up accessible and effective work-from-home measures
• Expanding online training opportunities
• Creating inclusive workplaces, whether virtual or physical
• Connecting people with disabilities and employers
• Training for in-demand jobs
• Wage subsidies

Location:
Vancouver, British Columbia, CA V6B2M1
Reference Number:
141-2020-2021-Q2-00012
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
129799961RC0001
Recipient Type:
Not-for-profit organization or charity
Additional Information:

COVID-19

Recipient's Legal Name:
Work Wellness and Disability Prevention Institute
Program:
National Workplace Accessibility Stream (NWAS) - Opportunities Fund
Program Purpose:

The purpose of the National Workplace Accessibility Stream of the Opportunities Fund for Persons with Disabilities (NWAS) is to help Canadians with disabilities and their employers to improve workplace accessibility and access to jobs in response to COVID-19.